Can Jardiance Be Used in CKD? eGFR Thresholds Explained
Yes, Jardiance is approved down to eGFR 20 at 10 mg daily per 2023 FDA labeling, based on EMPA-KIDNEY data; contraindicated in dialysis-dependent ESRD.
100 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 100 of 100 clinical reviews.
Yes, Jardiance is approved down to eGFR 20 at 10 mg daily per 2023 FDA labeling, based on EMPA-KIDNEY data; contraindicated in dialysis-dependent ESRD.
A clinical and coverage guide to Anthem (Elevance Health) formulary placement, prior authorization criteria, step therapy requirements, and appeal strategies for Jardiance (empagliflozin).
A clinical and insurance guide to Cigna coverage of empagliflozin (Jardiance): formulary tier, prior authorization criteria, step therapy requirements, appeal strategies, and cost-saving options for 2024 to 2025.
A guide to Humana's Jardiance (empagliflozin) coverage rules, formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial for type 2 diabetes, heart failure, or CKD.
A detailed guide to Kaiser Permanente's formulary tier, prior authorization criteria, step therapy requirements, and appeal process for Jardiance (empagliflozin) in 2024.
Find out whether Medicare Advantage plans cover Jardiance (empagliflozin), what formulary tier to expect, prior authorization requirements, step therapy rules, and how to appeal a denial.
A complete guide to TRICARE coverage for Jardiance (empagliflozin), including formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
How UnitedHealthcare typically handles Jardiance coverage: formulary tier patterns, prior authorization, step therapy, appeals, and cost options. Coverage details vary by specific plan and require verification with your benefit documents.
Standard empagliflozin dose is 10 mg daily, up to 25 mg for T2D. Heart failure and CKD stay fixed at 10 mg; renal function guides dosing, not age.
Empagliflozin starts at 10 mg daily for type 2 diabetes, max 25 mg. Heart failure dose stays at 10 mg. Check eGFR before starting; adjust for CKD as needed.
A guide to getting empagliflozin (Jardiance) in Alabama, covering telehealth prescribing, required labs, prior authorization, 503A compounding pharmacies, and local pharmacy options.
A complete guide to getting empagliflozin (Jardiance) in Arizona, including telehealth prescribing, lab requirements, prior authorization, pharmacy options, and transfer rules.
A complete clinical guide to obtaining empagliflozin (Jardiance) in California, including telehealth options, required labs, prior authorization steps, and pharmacy access.
A complete guide to obtaining empagliflozin (Jardiance) in Delaware, including telehealth options, prior authorization steps, lab requirements, pharmacy access, and real clinical data on who qualifies.
A complete guide to getting empagliflozin (Jardiance) in Florida, including telehealth prescribing, lab requirements, prior authorization, pharmacy options, and transfer rules.
A complete guide to obtaining empagliflozin (Jardiance) in Idaho, covering telehealth prescribing, labs, prior authorization, pharmacy options, and transfer rules, prepared by the HealthRX.com Editorial Team.
A complete guide to getting empagliflozin (Jardiance) in Indiana, covering telehealth prescribing, required labs, pharmacy options, prior authorization, and Indiana Medicaid coverage.
A complete guide to obtaining empagliflozin (Jardiance) in Kentucky, covering telehealth prescribing, required labs, prior authorization, pharmacy options, and Medicaid coverage rules.
A guide to obtaining empagliflozin (Jardiance) in Louisiana, covering telehealth prescribing, labs, prior authorization, pharmacy options, and Louisiana Medicaid coverage status.
A guide to obtaining empagliflozin (Jardiance) in Massachusetts via telehealth or in-person care, covering labs, prior authorization, pharmacy options, and dosing.
A guide to obtaining empagliflozin (Jardiance) in Michigan: telehealth prescribing rules, required labs, prior authorization, pharmacy options, and what the underlying clinical evidence actually supports.
A complete guide to obtaining empagliflozin (Jardiance) in Mississippi, including telehealth prescribers, required labs, pharmacy options, prior authorization, and insurance coverage under Mississippi Medicaid.
A complete guide to obtaining empagliflozin (Jardiance) in New Jersey, covering telehealth prescribing, required labs, prior authorization, pharmacy options, and the clinical evidence behind the drug.
A complete guide to getting empagliflozin (Jardiance) in North Carolina, including telehealth prescribing, required labs, pharmacy options, prior authorization, and cost-savings strategies.
A complete guide to getting empagliflozin (Jardiance) in Ohio, covering telehealth prescribing, required labs, prior authorization, pharmacy options, and clinical evidence for T2D, heart failure, and CKD.
A complete guide to getting empagliflozin (Jardiance) in Oregon, covering telehealth prescribing, labs, prior authorization, pharmacy options, and Oregon Medicaid coverage.
A complete guide to getting an empagliflozin (Jardiance) prescription in South Carolina, covering telehealth access, required labs, pharmacy options, prior authorization, and what to expect from your first dose.
A guide to obtaining empagliflozin (Jardiance) in South Dakota, covering telehealth prescribing, required labs, pharmacy options, prior authorization, and state Medicaid coverage.
A guide to obtaining empagliflozin (Jardiance) in Tennessee, covering who can prescribe it, what labs come first, how telehealth prescribing works, and where insurance coverage differs by payer.
A complete guide to obtaining empagliflozin (Jardiance) in Virginia, including telehealth prescribing, prior authorization, lab requirements, and pharmacy options.
A complete guide to obtaining empagliflozin (Jardiance) in West Virginia, covering telehealth prescribing, required labs, pharmacy options, prior authorization, and WV Medicaid status.
A complete guide to getting empagliflozin (Jardiance) in Wisconsin, covering telehealth prescribing, lab requirements, prior authorization, pharmacy options, and transfer rules.
Evidence-based guide to empagliflozin dosing in patients with liver disease, including pharmacokinetic data, FDA labeling, and clinical considerations for mild, moderate, and severe hepatic impairment.
Evidence-based guide to empagliflozin food and supplement interactions, including alcohol, grapefruit, diuretics, potassium, and common supplements that may affect SGLT2 inhibitor safety or efficacy.
Empagliflozin (Jardiance) reduces HbA1c by 0.7 to 0.8% and cut cardiovascular death by 38% in EMPA-REG OUTCOME. Full clinical evidence, dosing, side effects, and insurance coverage for type 2 diabetes.
A timeline of empagliflozin (Jardiance) development, from early SGLT2 research through FDA approvals for type 2 diabetes, cardiovascular risk reduction, heart failure, and chronic kidney disease, with notes on which claims are well established versus in need of primary-source verification.
Evidence-based guide to using empagliflozin (Jardiance) in special populations including organ transplant recipients, people living with HIV, older adults, and patients with hepatic or renal impairment.
A detailed look at how Jardiance (empagliflozin) is manufactured, its global supply chain, and a complete history of shortages reported to the FDA, with clinical context from EMPA-REG OUTCOME and beyond.
A complete clinical guide to monitoring empagliflozin (Jardiance) in adults aged 50, 64, covering kidney function, electrolytes, blood pressure, genital infections, and perimenopause and andropause considerations.
A complete clinical guide to empagliflozin monitoring for young adults ages 18 to 29, covering labs, kidney safety, fertility, contraception, and lifestyle integration with evidence-based thresholds.
Evidence-based monitoring guide for empagliflozin (Jardiance) in geriatric patients 65+, covering renal function, volume status, ketoacidosis screening, and deprescribing considerations.
A complete regulatory timeline for empagliflozin (Jardiance) across the FDA, EMA, Health Canada, and MHRA, including approved indications for type 2 diabetes, heart failure, and chronic kidney disease.
A guide to empagliflozin safety in young adults aged 18 to 29, covering cardiovascular benefits, genital infection risk, DKA, fertility, and dosing, with primary-source citations throughout.
Evidence-based safety profile of empagliflozin (Jardiance) for adults aged 30 to 49, covering adverse effects, monitoring, and a decision framework for common real-world scenarios.
A guide to empagliflozin (Jardiance): how the SGLT-2 inhibitor works, what EMPA-REG OUTCOME proved, correct oral dosing, and why no injection technique applies.
Evidence-based guide to empagliflozin (Jardiance) dosing in adolescents aged 12 to 17, including FDA-approved doses, off-label considerations, monitoring protocols, and clinical trial data.
Everything clinicians and families need to know about monitoring empagliflozin (Jardiance) in adolescents aged 12 to 17, including labs, growth tracking, DKA risk, and guideline-based follow-up schedules.
A complete clinical monitoring guide for empagliflozin (Jardiance) in adults aged 30-49, covering renal function, electrolytes, blood pressure, genital hygiene, and cardiovascular markers, with dosing thresholds and named trial evidence.
A PubMed-cited breakdown of every clinically significant drug-drug interaction with empagliflozin (Jardiance), including mechanism, magnitude, and management for T2D, heart failure, and CKD patients.
Jardiance costs $680/month cash in Arizona in 2026. Learn how Arizona Medicaid covers it, whether compounded empagliflozin is legal, and how to cut your cost to near zero with manufacturer savings cards or telehealth.
Complete 2026 guide to Jardiance (empagliflozin) cost in Arkansas, including Medicaid prior authorization rules, compounded empagliflozin legality, insurance coverage, and manufacturer savings card details.
Find out exactly what Jardiance (empagliflozin) costs in California in 2026, which insurance plans and Medi-Cal cover it, whether compounded empagliflozin is legal, and the fastest ways to lower your out-of-pocket cost.
Complete 2026 guide to empagliflozin (Jardiance) cost in Connecticut. Covers retail prices, CT Medicaid coverage, insurance tiers, manufacturer savings cards, and the legal status of compounded empagliflozin via 503A pharmacies.
Find out what Jardiance (empagliflozin) costs in Washington DC in 2026, how DC Medicaid covers it, whether compounded empagliflozin is legal, and how to lower your out-of-pocket cost with manufacturer savings cards and discount programs.
Jardiance (empagliflozin) costs around $680/month cash in Hawaii in 2026. Hawaii Medicaid does not cover it. Learn about insurance tiers, the BI/Lilly savings card, and legal 503A compounded empagliflozin alternatives available to Hawaii residents.
Find out exactly what Jardiance (empagliflozin) costs in Indiana in 2026, whether Indiana Medicaid covers it, how compounded empagliflozin works, and the fastest ways to cut your monthly bill.
Complete 2026 guide to empagliflozin (Jardiance) cost in Iowa: retail prices, Iowa Medicaid coverage status, compounded empagliflozin legality, savings cards, and telehealth access.
Jardiance (empagliflozin) costs about $680/month cash-pay in Kentucky in 2026. Learn about Kentucky Medicaid coverage gaps, compounded empagliflozin via 503A pharmacies, insurance options, and manufacturer savings cards that can cut your cost to $10/month.
Jardiance (empagliflozin) lists at $680/month in Louisiana. See how Medicaid, insurance, copay cards, and compounded empagliflozin change what you actually pay in 2026.
Complete 2026 guide to empagliflozin (Jardiance) costs in Maine, covering cash prices, MaineCare coverage, compounded empagliflozin legality, telehealth access, and manufacturer savings programs.
Showing the first 60 matches. Use search or filters to narrow the library.